Randomized Double-blind Placebo-controlled Study of KHK4577 in Patients With Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 11 Jul 2019
Price : $35 *
At a glance
- Drugs KHK 4577 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 03 Aug 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 08 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 10 Dec 2013 New trial record